NextGen Healthcare, Inc. (NASDAQ:NXGN) Shares Bought by Wade G W & Inc.

Wade G W & Inc. grew its position in NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) by 15.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 286,448 shares of the company’s stock after buying an additional 37,773 shares during the quarter. Wade G W & Inc. owned 0.43% of NextGen Healthcare worth $5,379,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. American Century Companies Inc. increased its holdings in NextGen Healthcare by 2.1% during the 1st quarter. American Century Companies Inc. now owns 50,366 shares of the company’s stock valued at $1,053,000 after acquiring an additional 1,031 shares in the last quarter. Natixis Advisors L.P. purchased a new position in shares of NextGen Healthcare during the 1st quarter worth approximately $280,000. MetLife Investment Management LLC raised its position in shares of NextGen Healthcare by 49.4% during the 1st quarter. MetLife Investment Management LLC now owns 32,724 shares of the company’s stock worth $684,000 after purchasing an additional 10,823 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of NextGen Healthcare by 11.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 48,421 shares of the company’s stock worth $1,012,000 after purchasing an additional 5,004 shares during the last quarter. Finally, APG Asset Management N.V. purchased a new stake in NextGen Healthcare in the 1st quarter valued at approximately $958,000. Institutional investors and hedge funds own 73.70% of the company’s stock.

Wall Street Analyst Weigh In

NXGN has been the subject of a number of analyst reports. Stephens assumed coverage on NextGen Healthcare in a report on Tuesday, April 11th. They issued an “overweight” rating and a $24.00 price target for the company. TheStreet lowered shares of NextGen Healthcare from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. Guggenheim lowered their price target on shares of NextGen Healthcare from $26.00 to $22.00 in a report on Tuesday. StockNews.com started coverage on shares of NextGen Healthcare in a research note on Thursday, May 18th. They set a “buy” rating on the stock. Finally, Piper Sandler decreased their target price on shares of NextGen Healthcare from $20.00 to $17.00 in a research report on Thursday, May 18th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $21.20.

NextGen Healthcare Trading Up 0.2 %

Shares of NXGN stock traded up $0.03 during trading hours on Friday, hitting $15.48. 136,694 shares of the company were exchanged, compared to its average volume of 406,374. The firm has a fifty day moving average of $16.98 and a 200 day moving average of $18.15. The company has a quick ratio of 2.53, a current ratio of 2.03 and a debt-to-equity ratio of 0.67. NextGen Healthcare, Inc. has a 1 year low of $15.23 and a 1 year high of $21.99. The firm has a market cap of $1.02 billion, a PE ratio of -386.25 and a beta of 1.04.

NextGen Healthcare Profile

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.